Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1981 1
1982 1
1983 2
1984 2
1985 2
1986 2
1987 3
1988 1
1989 5
1990 6
1991 5
1992 8
1993 1
1995 4
1996 3
1997 7
1998 12
1999 7
2000 6
2001 9
2002 4
2003 8
2004 8
2005 9
2006 8
2007 5
2008 13
2009 8
2010 8
2011 5
2012 11
2013 16
2014 17
2015 12
2016 9
2017 6
2018 18
2019 7
2020 10
2021 11
2022 8
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

281 results

Results by year

Filters applied: . Clear all
Page 1
EANO guidelines for the diagnosis and treatment of ependymal tumors.
Rudà R, Reifenberger G, Frappaz D, Pfister SM, Laprie A, Santarius T, Roth P, Tonn JC, Soffietti R, Weller M, Moyal EC. Rudà R, et al. Neuro Oncol. 2018 Mar 27;20(4):445-456. doi: 10.1093/neuonc/nox166. Neuro Oncol. 2018. PMID: 29194500 Free PMC article. Review.
In pediatric patients with intracranial ependymomas of WHO grades II or III, surgery is followed by local radiotherapy regardless of residual tumor volume. In adults, radiotherapy is employed in patients with anaplastic ependymoma WHO grade III, and in case of incomplete r …
In pediatric patients with intracranial ependymomas of WHO grades II or III, surgery is followed by local radiotherapy regardless of residua …
Treatment of anaplastic gliomas: evidences and controversies.
Geurts M, Snijders TJ, van den Bent MJ. Geurts M, et al. Curr Opin Oncol. 2021 Nov 1;33(6):621-625. doi: 10.1097/CCO.0000000000000785. Curr Opin Oncol. 2021. PMID: 34456249 Review.
RECENT FINDINGS: New biomarkers allow the identification of anaplastic glioma with relatively poor prognosis and with prognosis similar to glioblastoma. ...In the ongoing debate on the optimal chemotherapy regimen, a large retrospective study suggesting a better tumor cont …
RECENT FINDINGS: New biomarkers allow the identification of anaplastic glioma with relatively poor prognosis and with prognosis simil …
Entrectinib and other ALK/TRK inhibitors for the treatment of neuroblastoma.
Pacenta HL, Macy ME. Pacenta HL, et al. Drug Des Devel Ther. 2018 Oct 23;12:3549-3561. doi: 10.2147/DDDT.S147384. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 30425456 Free PMC article. Review.
ALK, TRKA, TRKB, TRKC, and ROS1 are RTKs involved in several canonical pathways related to oncogenesis. These proteins can be genetically altered in malignancies, leading to receptor activation and constitutive signaling through their respective downstream pathways. Neurob …
ALK, TRKA, TRKB, TRKC, and ROS1 are RTKs involved in several canonical pathways related to oncogenesis. These proteins can be genetically …
Cell death-based treatment of neuroblastoma.
Valter K, Zhivotovsky B, Gogvadze V. Valter K, et al. Cell Death Dis. 2018 Jan 25;9(2):113. doi: 10.1038/s41419-017-0060-1. Cell Death Dis. 2018. PMID: 29371588 Free PMC article. Review.
Moreover, NB is a complex disease that has high heterogeneity and is therefore difficult to target for successful therapy. Thus, a better understanding of NB development helps to improve treatment and increase the survival rate. One of the major causes of sporadic NB is kn …
Moreover, NB is a complex disease that has high heterogeneity and is therefore difficult to target for successful therapy. Thus, a be …
Radiation guidelines for gliomas.
Antoni D, Feuvret L, Biau J, Robert C, Mazeron JJ, Noël G. Antoni D, et al. Cancer Radiother. 2022 Feb-Apr;26(1-2):116-128. doi: 10.1016/j.canrad.2021.08.006. Epub 2021 Dec 22. Cancer Radiother. 2022. PMID: 34953698
The management of glioma patients is based on clinical factors (age, KPS) and tumour characteristics (histology, molecular biology, tumour location), and strongly depends on available and associated treatments, such as surgery, radiation therapy, and chemotherapy. The know …
The management of glioma patients is based on clinical factors (age, KPS) and tumour characteristics (histology, molecular biology, tumour l …
Anaplastic Glioma: Treatment Approaches in the Era of Molecular Diagnostics.
Ruff MW, Uhm J. Ruff MW, et al. Curr Treat Options Oncol. 2018 Oct 25;19(12):61. doi: 10.1007/s11864-018-0579-0. Curr Treat Options Oncol. 2018. PMID: 30361986 Review.
The treatment paradigm for anaplastic glioma has shifted, owing to new diagnostic criteria and new phase III clinical trial evidence. ...Recently, the benefit of adjuvant chemotherapy in addition to radiotherapy has been demonstrated in both anaplastic oligodendrogl …
The treatment paradigm for anaplastic glioma has shifted, owing to new diagnostic criteria and new phase III clinical trial evidence. …
Anaplastic glioma: current treatment and management.
Le Rhun E, Taillibert S, Chamberlain MC. Le Rhun E, et al. Expert Rev Neurother. 2015 Jun;15(6):601-20. doi: 10.1586/14737175.2015.1042455. Epub 2015 May 2. Expert Rev Neurother. 2015. PMID: 25936680 Review.
Anaplastic glioma (AG) is divided into three morphology-based groups (anaplastic astrocytoma, anaplastic oligodendroglioma, anaplastic oligoastrocytoma) as well as three molecular groups (glioma-CpG island methylation phenotype [G-CIMP] negative, G-CIM …
Anaplastic glioma (AG) is divided into three morphology-based groups (anaplastic astrocytoma, anaplastic oligodendrogli …
Treatment of anaplastic glioma.
Wick W, Wiestler B, Platten M. Wick W, et al. Cancer Treat Res. 2015;163:89-101. doi: 10.1007/978-3-319-12048-5_6. Cancer Treat Res. 2015. PMID: 25468227 Review.
Anaplastic gliomas have received increasing attention over the past years. As opposed to glioblastoma, where the focus has been on the evaluation of novel compounds (with mainly disappointing results), in anaplastic gliomas relevant progress was generated with genot …
Anaplastic gliomas have received increasing attention over the past years. As opposed to glioblastoma, where the focus has been on th …
Increasing feasibility and utility of (18)F-FDOPA PET for the management of glioma.
Bell C, Dowson N, Puttick S, Gal Y, Thomas P, Fay M, Smith J, Rose S. Bell C, et al. Nucl Med Biol. 2015 Oct;42(10):788-95. doi: 10.1016/j.nucmedbio.2015.06.001. Epub 2015 Jun 9. Nucl Med Biol. 2015. PMID: 26162582 Review.
INTRODUCTION: Despite radical treatment therapies, glioma continues to carry with it a uniformly poor prognosis. Patients diagnosed with WHO Grade IV glioma (glioblastomas; GBM) generally succumb within two years, even those with WHO Grade III anaplastic gliomas and …
INTRODUCTION: Despite radical treatment therapies, glioma continues to carry with it a uniformly poor prognosis. Patients diagnosed w …
Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomas.
Lecavalier-Barsoum M, Quon H, Abdulkarim B. Lecavalier-Barsoum M, et al. Cochrane Database Syst Rev. 2014 May 15;2014(5):CD007104. doi: 10.1002/14651858.CD007104.pub2. Cochrane Database Syst Rev. 2014. PMID: 24833028 Free PMC article. Review.
BACKGROUND: Standard care of adjuvant treatment for anaplastic oligodendrogliomas (AO) and anaplastic oligoastrocytomas (AOA) is not yet well defined. ...SELECTION CRITERIA: We included randomized controlled trials (RCTs) of adults with AO, AOA or anaplast …
BACKGROUND: Standard care of adjuvant treatment for anaplastic oligodendrogliomas (AO) and anaplastic oligoastrocytomas …
281 results